GetTopicDetailResponse(id=a5581082158, topicName=lesinurad, introduction=lesinurad, content=null, image=null, comments=4, allHits=1008, url=https://h5.medsci.cn/topic?id=10821, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=29928, tagList=[TagDto(tagId=29928, tagName=lesinurad)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1987749, encodeId=2e59198e749bf, content=<a href='/topic/show?id=a5581082158' target=_blank style='color:#2F92EE;'>#lesinurad#</a>, objectTitle=FDA批準(zhǔn)阿斯利康痛風(fēng)藥物L(fēng)esinurad治療痛風(fēng)相關(guān)高尿酸血癥, objectType=article, longId=61082, objectId=60d0610827d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60d0610827d, replyNumber=0, likeNumber=118, createdTime=2016-01-13, rootId=0, userName=liye789132251, userId=2e6f107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60d0610827d, moduleTitle=FDA批準(zhǔn)阿斯利康痛風(fēng)藥物L(fēng)esinurad治療痛風(fēng)相關(guān)高尿酸血癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=60d0610827d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987748, encodeId=0650198e748be, content=<a href='/topic/show?id=a5581082158' target=_blank style='color:#2F92EE;'>#lesinurad#</a>, objectTitle=重磅炸彈！FDA委員會(huì)通過了用于痛風(fēng)治療的新藥——lesinurad, objectType=article, longId=58062, objectId=4b07580623b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b07580623b, replyNumber=0, likeNumber=114, createdTime=2016-06-13, rootId=0, userName=liye789132251, userId=2e6f107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b07580623b, moduleTitle=重磅炸彈！FDA委員會(huì)通過了用于痛風(fēng)治療的新藥——lesinurad, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4b07580623b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987747, encodeId=5ce3198e747ab, content=<a href='/topic/show?id=a5581082158' target=_blank style='color:#2F92EE;'>#lesinurad#</a>, objectTitle=阿斯利康$12.6億痛風(fēng)藥物lesinurad提交歐盟審查, objectType=article, longId=46037, objectId=0caa4603ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0caa4603ece, replyNumber=0, likeNumber=75, createdTime=2015-05-29, rootId=0, userName=liye789132251, userId=2e6f107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0caa4603ece, moduleTitle=阿斯利康$12.6億痛風(fēng)藥物lesinurad提交歐盟審查, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0caa4603ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987746, encodeId=4757198e74664, content=<a href='/topic/show?id=a5581082158' target=_blank style='color:#2F92EE;'>#lesinurad#</a>, objectTitle=阿斯利康$12.6億痛風(fēng)藥物lesinurad III期項(xiàng)目成功, objectType=article, longId=39120, objectId=271f3912019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=271f3912019, replyNumber=0, likeNumber=101, createdTime=2014-11-08, rootId=0, userName=liye789132251, userId=2e6f107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=271f3912019, moduleTitle=阿斯利康$12.6億痛風(fēng)藥物lesinurad III期項(xiàng)目成功, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=271f3912019)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
